Lisa Roth, MD, is an Associate Professor of Pediatrics in the Division of Pediatric Hematology/Oncology at Weill Cornell Medical College. She serves as the Director of Pediatric Oncology at Weill Cornell Medicine and New York-Presbyterian Hospital.  Dr. Roth completed her undergraduate work at Duke University. She received her medical degree from New York University School of Medicine followed by a residency in Pediatrics at New York-Presbyterian/Weill Cornell a fellowship in Pediatric Hematology/Oncology at Memorial Sloan-Kettering Cancer Center and New York-Presbyterian where she served as chief fellow.  Dr. Roth’s laboratory research focuses on identifying novel therapeutic targets for pediatric lymphomas including Hodgkin lymphoma and aggressive B-cell non-Hodgkin lymphoma.  She is particularly interested in lymphomas associated with EBV and has been studying mechanisms to modulate the virus in these tumors to sensitize tumors to immunotherapy.  Her laboratory work is closely tied to her clinical research where she is leading several national clinical trials focused on advancing therapy for children, adolescents, and young adults with Hodgkin and non-Hodgkin lymphoma.